The Cardiopulmonary Exercise Testing Market is led by North America, which holds approximately 45% of the global market. The region benefits from advanced healthcare infrastructure, high adoption of diagnostic technologies, and significant investment in cardiovascular and respiratory care.

Europe represents the second-largest regional market, accounting for approximately 30% of global share. Germany, France, and the UK are important markets where healthcare providers are increasingly incorporating CPET into diagnostic and rehabilitation programs.

Asia-Pacific is emerging as the fastest-growing region, with approximately 20% of the market. Rising healthcare investment, expanding hospital infrastructure, increasing awareness of preventive healthcare, and the growing burden of lifestyle-related diseases are supporting adoption in countries including China and India.

Key companies identified by Market Research Future include Cardinal Health, Philips, GE Healthcare, Schiller AG, MediSoft, COSMED, KORR Medical Technologies, Bodystat, and Vyaire Medical.

With the market projected to reach USD 2.09 billion by 2035, continued advances in portable testing devices, AI-based analytics, software platforms, and telehealth integration are expected to create significant opportunities across the global cardiopulmonary exercise testing industry.